Skip to main content
Erschienen in: Digestive Diseases and Sciences 11/2013

01.11.2013 | Original Article

Use of a Low Cut-Off Value for the Fecal Immunochemical Test Enables Better Detection of Proximal Neoplasia

verfasst von: Jae Myung Cha, Joung Il Lee, Kwang Ro Joo, Hyun Phil Shin, Jung Won Jeun, Jun Uk Lim

Erschienen in: Digestive Diseases and Sciences | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

The advantage of the quantitative fecal immunochemical test (FIT) is the flexibility to set the positivity threshold. However, the diagnostic success of the FIT has not been compared for standard and low cut-off thresholds.

Aims

The purpose of this study was to compare the diagnostic success of FIT for standard and low cut-off thresholds.

Methods

In 2009 and 2010 a standard cut-off threshold (20 μg Hb/g feces) was used as positivity criterion for the FIT; in 2012 a low cut-off (10 μg Hb/g feces) was used. Diagnostic success was compared between the two groups.

Results

Of the total of 14,289 participants, 195 (1.4 %) had positive FIT results. Positivity of the FIT was significantly higher in the low cut-off group than in the standard cut-off group (1.8 vs. 1.0 %, p = 0.000). Although detection of advanced neoplasia lesions was comparable, proximal neoplasia was more frequently detected in the low cut-off group (33.3 vs. 20.9 %, p = 0.016). With the low cut-off threshold, 39 (0.7 %) participants were also classified as having positive results, and 18 (46.2 %) of these had colorectal neoplasias. The number of positive results from the FIT was increased by 54.9 %, and detection of advanced neoplasia was increased by 60 % with the low cut-off threshold compared with the standard cut-off.

Conclusions

A low cut-off threshold for the FIT resulted in better detection of proximal neoplasia in population-based screening. These results indicate the cut-off threshold for positive FIT should be properly chosen and adjusted in colorectal cancer screening.
Literatur
1.
Zurück zum Zitat Choi KS, Jun JK, Lee HY, Hahm MI, Oh JH, Park EC. Increasing uptake of colorectal cancer screening in Korea: a population-based study. BMC Public Health.. 2010;10:265.PubMedCrossRef Choi KS, Jun JK, Lee HY, Hahm MI, Oh JH, Park EC. Increasing uptake of colorectal cancer screening in Korea: a population-based study. BMC Public Health.. 2010;10:265.PubMedCrossRef
2.
Zurück zum Zitat Shim JI, Kim Y, Han MA, et al. Results of colorectal cancer screening of the national cancer screening program in Korea, 2008. Cancer Res Treat.. 2010;42:191–198.PubMedCrossRef Shim JI, Kim Y, Han MA, et al. Results of colorectal cancer screening of the national cancer screening program in Korea, 2008. Cancer Res Treat.. 2010;42:191–198.PubMedCrossRef
3.
Zurück zum Zitat Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening of colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993;85:1311–1318.PubMedCrossRef Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening of colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993;85:1311–1318.PubMedCrossRef
4.
Zurück zum Zitat Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603–1607.PubMedCrossRef Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603–1607.PubMedCrossRef
5.
Zurück zum Zitat Atkin WS, Cuzick J, Northover JM, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993;341:736–740.PubMedCrossRef Atkin WS, Cuzick J, Northover JM, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993;341:736–740.PubMedCrossRef
6.
Zurück zum Zitat Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl J Med. 1993;328:1365e71. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl J Med. 1993;328:1365e71.
7.
Zurück zum Zitat Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477.PubMedCrossRef Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477.PubMedCrossRef
8.
Zurück zum Zitat Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–1471.PubMedCrossRef Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–1471.PubMedCrossRef
9.
Zurück zum Zitat Jørgensen OD, Kronborg O, Fenger C. A randomized study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut. 2002;50:29–32.PubMedCrossRef Jørgensen OD, Kronborg O, Fenger C. A randomized study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut. 2002;50:29–32.PubMedCrossRef
10.
Zurück zum Zitat Young GP, St John DJ, Winawer SJ, Rozen P; WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy). Choice of fecal occult blood test for screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol. 2002;97:2499–2507. Young GP, St John DJ, Winawer SJ, Rozen P; WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy). Choice of fecal occult blood test for screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol. 2002;97:2499–2507.
11.
Zurück zum Zitat Grazzini G, Visioli CB, Zorzi M, et al. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer. 2009;100:259–265.PubMedCrossRef Grazzini G, Visioli CB, Zorzi M, et al. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer. 2009;100:259–265.PubMedCrossRef
12.
Zurück zum Zitat Leiberman DA, Holub J, Eisen G, Kraemer D, Morris CD. Utilization of colonoscopy in the United States: results from a national consortium. Gastrointest Endosc. 2005;62:875–883.CrossRef Leiberman DA, Holub J, Eisen G, Kraemer D, Morris CD. Utilization of colonoscopy in the United States: results from a national consortium. Gastrointest Endosc. 2005;62:875–883.CrossRef
13.
Zurück zum Zitat Guittet L, Bouvier V, Mariotte N, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut. 2007;56:210–214.PubMedCrossRef Guittet L, Bouvier V, Mariotte N, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut. 2007;56:210–214.PubMedCrossRef
14.
Zurück zum Zitat Fenocchi E, Martinez L, Tolve J, et al. Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test. Eur J Cancer Prev. 2006;15:384–390.PubMedCrossRef Fenocchi E, Martinez L, Tolve J, et al. Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test. Eur J Cancer Prev. 2006;15:384–390.PubMedCrossRef
15.
Zurück zum Zitat Rubeca T, Rapi S, Confortini M, et al. Evaluation of diagnostic accuracy of screening by fecal occult blood testing (FOBT). Comparison of FOB Gold and OC Sensor assays in a consecutive prospective screening series. Int J Biol Markers.. 2006;21:157–161.PubMed Rubeca T, Rapi S, Confortini M, et al. Evaluation of diagnostic accuracy of screening by fecal occult blood testing (FOBT). Comparison of FOB Gold and OC Sensor assays in a consecutive prospective screening series. Int J Biol Markers.. 2006;21:157–161.PubMed
16.
Zurück zum Zitat Grazzini G, Gastiglione G, Ciabattoni C, et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev. 2004;13:19–26.PubMedCrossRef Grazzini G, Gastiglione G, Ciabattoni C, et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev. 2004;13:19–26.PubMedCrossRef
17.
Zurück zum Zitat Sohn DK, Jeong SY, Choi HS, et al. Single immunochemical fecal occult blood test for detection of colorectal neoplasia. Cancer Res Treat.. 2005;37:20–23.PubMedCrossRef Sohn DK, Jeong SY, Choi HS, et al. Single immunochemical fecal occult blood test for detection of colorectal neoplasia. Cancer Res Treat.. 2005;37:20–23.PubMedCrossRef
18.
Zurück zum Zitat Castiglione G, Grazzini G, Miccinesi G, et al. Basic variables at different positivity thresholds of an quantitative immunochemical test for faecal occult blood. J Med Screen. 2002;9:99–103.PubMedCrossRef Castiglione G, Grazzini G, Miccinesi G, et al. Basic variables at different positivity thresholds of an quantitative immunochemical test for faecal occult blood. J Med Screen. 2002;9:99–103.PubMedCrossRef
19.
Zurück zum Zitat Park DI, Ryu S, Kim YH, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average-risk undergoing colorectal cancer screening. Am J Gastroenterol. 2010;105:2017–2025.PubMedCrossRef Park DI, Ryu S, Kim YH, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average-risk undergoing colorectal cancer screening. Am J Gastroenterol. 2010;105:2017–2025.PubMedCrossRef
20.
Zurück zum Zitat Omata F, Shintani A, Isozaki M, et al. Diagnostic performance of quantitative fecal immunochemical test and multivariate prediction model for colorectal neoplasms in asymptomatic individuals. Eur J Gastroenterol Hepatol. 2011;23:1036–1041.PubMed Omata F, Shintani A, Isozaki M, et al. Diagnostic performance of quantitative fecal immunochemical test and multivariate prediction model for colorectal neoplasms in asymptomatic individuals. Eur J Gastroenterol Hepatol. 2011;23:1036–1041.PubMed
21.
Zurück zum Zitat Rozen P, Levi Z, Hazazi R, et al. Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms. Aliment Pharmacol Ther. 2009;29:450–457. Rozen P, Levi Z, Hazazi R, et al. Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms. Aliment Pharmacol Ther. 2009;29:450–457.
22.
Zurück zum Zitat Yoo KY. Cancer control activities in the republic of Korea. Jpn J Clin Oncol.. 2008;38:327–333.PubMedCrossRef Yoo KY. Cancer control activities in the republic of Korea. Jpn J Clin Oncol.. 2008;38:327–333.PubMedCrossRef
23.
Zurück zum Zitat Cha JM, Lee JI, Joo KR, Shin HP, Park JJ. Telephone reminder call in addition to mailing notification improved the acceptance rate of colonoscopy in patients with a positive fecal immunochemical test. Dig Dis Sci. 2011;56:3137–3142.PubMedCrossRef Cha JM, Lee JI, Joo KR, Shin HP, Park JJ. Telephone reminder call in addition to mailing notification improved the acceptance rate of colonoscopy in patients with a positive fecal immunochemical test. Dig Dis Sci. 2011;56:3137–3142.PubMedCrossRef
24.
Zurück zum Zitat Fraser CG, Allison JE, Halloran SP, Young GP. Expert working group on fecal immunochemical tests for hemoglobin, colorectal cancer screening committee, world endoscopy organization. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J Natl Cancer Inst. 2012;104:810–814.PubMedCrossRef Fraser CG, Allison JE, Halloran SP, Young GP. Expert working group on fecal immunochemical tests for hemoglobin, colorectal cancer screening committee, world endoscopy organization. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J Natl Cancer Inst. 2012;104:810–814.PubMedCrossRef
25.
Zurück zum Zitat Terhaarsive Droste JS, Oort FA, van der Hulst RW, et al. Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancers. Cancer Epidemiol Biomarkers Prev. 2011;20:272–280. Terhaarsive Droste JS, Oort FA, van der Hulst RW, et al. Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancers. Cancer Epidemiol Biomarkers Prev. 2011;20:272–280.
26.
Zurück zum Zitat Haug U, Hundt S, Brenner H. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests. Am J Gastroenterol. 2010;105:682–690.PubMedCrossRef Haug U, Hundt S, Brenner H. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests. Am J Gastroenterol. 2010;105:682–690.PubMedCrossRef
27.
Zurück zum Zitat Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med. 2007;146:244–255.PubMedCrossRef Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med. 2007;146:244–255.PubMedCrossRef
28.
Zurück zum Zitat Wilschut JA, Hol L, Dekker E, et al. Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. Gastroenterology. 2011;141:1648–1655.PubMedCrossRef Wilschut JA, Hol L, Dekker E, et al. Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. Gastroenterology. 2011;141:1648–1655.PubMedCrossRef
29.
Zurück zum Zitat Sobhani I, Alzahouri K, Ghout I, Charles DJ, Durand-Zaleski I. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy. Dis Colon Rectum. 2011;54:876–886.PubMedCrossRef Sobhani I, Alzahouri K, Ghout I, Charles DJ, Durand-Zaleski I. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy. Dis Colon Rectum. 2011;54:876–886.PubMedCrossRef
30.
Zurück zum Zitat Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129:422–428.PubMed Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129:422–428.PubMed
31.
Zurück zum Zitat Haug U, Kuntz KM, Knudsen AB, et al. Sensitivity of immunochemical faecal occult blood testing for detecting left- vs. right-sided colorectal neoplasia. Br J Cancer. 2011;104:1779–1785.PubMedCrossRef Haug U, Kuntz KM, Knudsen AB, et al. Sensitivity of immunochemical faecal occult blood testing for detecting left- vs. right-sided colorectal neoplasia. Br J Cancer. 2011;104:1779–1785.PubMedCrossRef
32.
Zurück zum Zitat Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer: a population-based, case-control study. Ann Intern Med. 2009;150:1–8.PubMedCrossRef Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer: a population-based, case-control study. Ann Intern Med. 2009;150:1–8.PubMedCrossRef
33.
Zurück zum Zitat Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med. 2011;154:22–30.PubMedCrossRef Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med. 2011;154:22–30.PubMedCrossRef
34.
Zurück zum Zitat Van Rossum LG, Van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and fecal immunochemical blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135:82–90.PubMedCrossRef Van Rossum LG, Van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and fecal immunochemical blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135:82–90.PubMedCrossRef
35.
Zurück zum Zitat Van Roon AH, Wilschut JA, Hol L, et al. Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance. Clin Gastroenterol Hepatol.. 2011;9:333–339.PubMedCrossRef Van Roon AH, Wilschut JA, Hol L, et al. Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance. Clin Gastroenterol Hepatol.. 2011;9:333–339.PubMedCrossRef
36.
Zurück zum Zitat Cha JM, Lee JI, Joo KR, et al. Performance of the fecal immunochemical test is not decreased by high ambient temperature in the rapid return system. Dig Dis Sci. 2012;57:2178–2183.PubMedCrossRef Cha JM, Lee JI, Joo KR, et al. Performance of the fecal immunochemical test is not decreased by high ambient temperature in the rapid return system. Dig Dis Sci. 2012;57:2178–2183.PubMedCrossRef
37.
Zurück zum Zitat Cha JM, Lee JI, Joo KR, Shin HP, Park JJ. Telephone reminder call in addition to mailing notification improved the acceptance rate of colonoscopy in patient with a positive fecal immunochemical test. Dig Dis Sci. 2011;56:3137–3142.PubMedCrossRef Cha JM, Lee JI, Joo KR, Shin HP, Park JJ. Telephone reminder call in addition to mailing notification improved the acceptance rate of colonoscopy in patient with a positive fecal immunochemical test. Dig Dis Sci. 2011;56:3137–3142.PubMedCrossRef
Metadaten
Titel
Use of a Low Cut-Off Value for the Fecal Immunochemical Test Enables Better Detection of Proximal Neoplasia
verfasst von
Jae Myung Cha
Joung Il Lee
Kwang Ro Joo
Hyun Phil Shin
Jung Won Jeun
Jun Uk Lim
Publikationsdatum
01.11.2013
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 11/2013
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-013-2819-2

Weitere Artikel der Ausgabe 11/2013

Digestive Diseases and Sciences 11/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.